{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:24:09Z","timestamp":1759411449314},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1007\/s11908-004-0022-5","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T02:57:59Z","timestamp":1180061879000},"page":"34-42","source":"Crossref","is-referenced-by-count":19,"title":["Yellow fever immunizations: Indications and risks"],"prefix":"10.1007","volume":"6","author":[{"given":"Mary E.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin H.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth D.","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"22_CR1","first-page":"1095","volume-title":"Vaccines","author":"TP Monath","year":"2004","unstructured":"Monath TP: Yellow fever. In Vaccines, edn 4. Edited by Plotkin SA, Orenstein WA. Philadelphia: WB Saunders; 2004:1095\u20131176. This is a superb, detailed chapter that provides history of yellow fever vaccine and up-to-date information about its preparation, characteristics, and use.","edition":"edn 4"},{"key":"22_CR2","unstructured":"Fever, jaundice, and multiple organ system failure associated with 17D-derived yellow fever vaccination, 1996\u20132001. MMWR Morb Mortal Wkly Rep 2001, 50:643\u2013645."},{"key":"22_CR3","unstructured":"Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002. MMWR Morb Mortal Wkly Rep 2002, 51:1\u201311."},{"key":"22_CR4","unstructured":"Adverse events associated with 17D-derived yellow fever vaccination\u2014United States, 2001\u20132002. MMWR Morb Mortal Wkly Rep 2002, 51:993."},{"key":"22_CR5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(01)05341-7","volume":"358","author":"RC Chan","year":"2001","unstructured":"Chan RC, Penney DJ, Little D, et al.: Hepatitis and death following vaccination with 17D-204 yellow fever vaccine. Lancet 2001, 358:121\u2013122.","journal-title":"Lancet"},{"key":"22_CR6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","volume":"358","author":"M Martin","year":"2001","unstructured":"Martin M, Tsai TF, Cropp B, et al.: Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases. Lancet 2001, 358:98\u2013104.","journal-title":"Lancet"},{"key":"22_CR7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(01)05326-0","volume":"358","author":"PF Vasconcelos","year":"2001","unstructured":"Vasconcelos PF, Lund EJ, Galler R, et al.: Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases. Lancet 2001, 358:91\u201397.","journal-title":"Lancet"},{"key":"22_CR8","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/jama.1996.03540140045025","volume":"276","author":"SE Robertson","year":"1996","unstructured":"Robertson SE, Hull BP, Tomori O, et al.: Yellow fever: a decade of reemergence. JAMA 1996, 276:1157\u20131162. This is an excellent general review of expansion of yellow fever transmission.","journal-title":"JAMA"},{"key":"22_CR9","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S1286-4579(02)00028-X","volume":"4","author":"JP Mutebi","year":"2002","unstructured":"Mutebi JP, Barrett AD: The epidemiology of yellow fever in Africa. Microbes Infect 2002, 4:1459\u20131468. This is a detailed discussion of past and current epidemiology of yellow fever in Africa.","journal-title":"Microbes Infect"},{"key":"22_CR10","volume-title":"Report on Global Surveillance of Epidemic-prone Infectious Diseases, 2000","author":"World Health Organization","year":"2000","unstructured":"World Health Organization: Yellow fever. In Report on Global Surveillance of Epidemic-prone Infectious Diseases, 2000. Geneva: World Health Organization; 2000. www.who.int\/emc-documents\/ surveillance\/docs\/whocdscsrisr2001.pdf\/index.html."},{"key":"22_CR11","first-page":"354","volume":"73","author":"World Health Organization","year":"1998","unstructured":"World Health Organization: Yellow fever, 1996\u20131997. Wkly Epidemiol Rec 1998, 73:354\u2013359.","journal-title":"Wkly Epidemiol Rec"},{"key":"22_CR12","first-page":"322","volume":"75","author":"World Health Organization","year":"2000","unstructured":"World Health Organization: Yellow fever, 1998\u20131999. Wkly Epidemiol Rec 2000, 75:322\u2013328.","journal-title":"Wkly Epidemiol Rec"},{"key":"22_CR13","unstructured":"World Health Organization: Disease outbreak news\u2014yellow fever. http:\/\/www.who.int\/disease-outbreak-news\/disease\/ A95.htm. Accessed August 20, 2003."},{"key":"22_CR14","unstructured":"Pan American Health Organization: Yellow fever\u2014number of cases and deaths notified to PAHO, 1985\u20132003. http:\/\/ www.paho.org\/English\/AD\/FCH\/IM\/2003_07_09_yf85-03.pdf. Accessed August 20, 2003."},{"key":"22_CR15","first-page":"348","volume":"78","author":"World Health Organization","year":"2003","unstructured":"World Health Organization: International health regulations. Wkly Epidemiol Rec 2003, 78:348.","journal-title":"Wkly Epidemiol Rec"},{"key":"22_CR16","first-page":"365","volume":"78","author":"World Health Organization","year":"2003","unstructured":"World Health Organization: Yellow fever, Burkina Faso. Wkly Epidemiol Rec 2003, 78:365\u2013372.","journal-title":"Wkly Epidemiol Rec"},{"key":"22_CR17","unstructured":"World Health Organization: Yellow fever in Sierra Leone-update. http:\/\/www.who.int\/csr\/don\/2003_09_30a\/en. Accessed October 17, 2003."},{"key":"22_CR18","unstructured":"Pan American Health Organization: Update on yellow fever in Latin America. Emerging and reemerging infectious diseases. http:\/\/www.paho.org\/English\/AD\/DPC\/CD\/eid-eer-09-oct-2003.htm. Accessed October 17, 2003."},{"key":"22_CR19","volume-title":"Yellow Fever","author":"J Vainio","year":"1998","unstructured":"Vainio J, Cutts F: Yellow Fever. Geneva: World Health Organization; 1998. http:\/\/www.who.int\/vaccines-documents\/docsPDF\/ www9842.pdf This is a detailed review (87 pages) of yellow fever and vaccine use, including many maps and tables."},{"key":"22_CR20","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/S0140-6736(99)03291-2","volume":"353","author":"P Stuyft Van der","year":"1999","unstructured":"Van der Stuyft P, Gianella A, Piard M, et al.: Urbanisation of yellow fever in Santa Cruz, Bolivia. Lancet 1999, 353:1558\u20131562.","journal-title":"Lancet"},{"key":"22_CR21","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3201\/eid0908.030075","volume":"9","author":"J Bryant","year":"2003","unstructured":"Bryant J, Wang H, Cabezas C, et al.: Enzootic transmission of yellow fever virus in Peru. Emerg Infect Dis 2003, 9:926\u2013933.","journal-title":"Emerg Infect Dis"},{"key":"22_CR22","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/jmv.10226","volume":"68","author":"AM Filippis de","year":"2002","unstructured":"de Filippis AM, Nogueira RM, Schatzmayr HG, et al.: Outbreak of jaundice and hemorrhagic fever in the southeast of Brazil in 2001: detection and molecular characterization of yellow fever virus. J Med Virol 2002, 68:620\u2013627.","journal-title":"J Med Virol"},{"key":"22_CR23","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0140-6736(05)65392-5","volume":"348","author":"MO Barros","year":"1996","unstructured":"Barros MO, Boecken G: Jungle yellow fever in the central Amazon. Lancet 1996, 348:969.","journal-title":"Lancet"},{"key":"22_CR24","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1086\/516111","volume":"25","author":"JM McFarland","year":"1997","unstructured":"McFarland JM, Baddour LM, Nelson JE, et al.: Imported yellow fever in a US citizen. Clin Infect Dis 1997, 25:1143\u20131147.","journal-title":"Clin Infect Dis"},{"key":"22_CR25","unstructured":"Fatal yellow fever in a traveler returning from Venezuela, 1999. MMWR Morb Mortal Wkly Rep 2000, 49:303\u2013305."},{"key":"22_CR26","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0140-6736(99)09233-8","volume":"354","author":"D Teichmann","year":"1999","unstructured":"Teichmann D, Grobusch MP, Wesselmann H, et al.: A hemorrhagic fever from the Cote d\u2019Ivoire. Lancet 1999, 354:1608.","journal-title":"Lancet"},{"key":"22_CR27","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1086\/344180","volume":"35","author":"R Colebunders","year":"2002","unstructured":"Colebunders R, Mariage JL, Coche JC, et al.: A Belgian traveler who acquired yellow fever in the Gambia. Clin Infect Dis 2002, 35:e113-e116.","journal-title":"Clin Infect Dis"},{"key":"22_CR28","unstructured":"Fatal yellow fever in a traveler returning from Amazonas, Brazil, 2002. MMWR Morb Mortal Wkly Rep 2002, 51:324\u2013325."},{"key":"22_CR29","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1086\/340104","volume":"34","author":"TP Monath","year":"2002","unstructured":"Monath TP, Cetron MS: Prevention of yellow fever in persons traveling to the tropics. Clin Infect Dis 2002, 34:1369\u20131378. This excellent paper addresses the use of yellow fever vaccine in travelers and provides quantitative estimates of risk for areas with endemic and epidemic activity.","journal-title":"Clin Infect Dis"},{"key":"22_CR30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B","volume":"56","author":"B Reinhardt","year":"1998","unstructured":"Reinhardt B, Jaspert R, Neidrig M, et al.: Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection. J Med Virol 1998, 56:159\u2013167.","journal-title":"J Med Virol"},{"key":"22_CR31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0168-1702(98)00036-7","volume":"55","author":"H Xie","year":"1998","unstructured":"Xie H, Cass AR, Barrett AD: Yellow fever 17D vaccine virus isolated from healthy vaccinees accumulates very few mutations. Virus Research 1998, 55:93\u201399.","journal-title":"Virus Research"},{"key":"22_CR32","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0264-410X(01)00439-X","volume":"20","author":"KV Pugachev","year":"2002","unstructured":"Pugachev KV, Ocran S, Guirakhoo F, et al.: Heterogeneous nature of the genome of the ARILVAX yellow fever 17D vaccine revealed by consensus sequencing. Vaccine 2002, 20:966\u2013999.","journal-title":"Vaccine"},{"key":"22_CR33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1099\/0022-1317-64-3-627","volume":"64","author":"TP Monath","year":"1983","unstructured":"Monath TP, Kenney RM, Schlesinger JJ, et al.: Ontogeny of yellow fever 17D vaccine: RNA oligonucleotide fingerprint and monoclonal antibody analyses of vaccines produced worldwide. J Gen Virol 1983, 64:229\u2013637.","journal-title":"J Gen Virol"},{"key":"22_CR34","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.4269\/ajtmh.1999.60.1045","volume":"60","author":"J Lang","year":"1999","unstructured":"Lang J, Zuckerman J, Clarke P, et al.: Comparison of the immunogenicity and safety of two 17D yellow fever vaccines. Am J Trop Med Hyg 1999, 60:1045\u20131050.","journal-title":"Am J Trop Med Hyg"},{"key":"22_CR35","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4269\/ajtmh.2002.66.533","volume":"66","author":"TP Monath","year":"2002","unstructured":"Monath TP, Nichols R, Archambault WT, et al.: Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter doubleblind clinical trial. Am J Trop Med Hyg 2002, 66:533\u2013541.","journal-title":"Am J Trop Med Hyg"},{"key":"22_CR36","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0091-6749(99)70245-9","volume":"4","author":"JM Kelso","year":"1999","unstructured":"Kelso JM, Mootrey GT, Tsai TF: Anaphylaxis from yellow fever vaccine. J Allergy Clin Immunol 1999, 4:698\u2013701.","journal-title":"J Allergy Clin Immunol"},{"key":"22_CR37","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/infdis\/169.3.512","volume":"169","author":"AD Jennings","year":"1994","unstructured":"Jennings AD, Gibson CA, Miller BR, et al.: Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis. J Infect Dis 1994, 169:512\u2013518.","journal-title":"J Infect Dis"},{"key":"22_CR38","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3201\/eid0706.010605","volume":"7","author":"M Martin","year":"2001","unstructured":"Martin M, Weld LH, Tsai TF, et al.: Advanced age a risk factor for illness temporally associated with yellow fever vaccination. Emerg Infect Dis 2001, 7:945\u2013951.","journal-title":"Emerg Infect Dis"},{"key":"22_CR39","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/viro.2001.1168","volume":"290","author":"R Galler","year":"2001","unstructured":"Galler R, Pugachev KV, Santos LE, et al.: Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil. Virology 2001, 290:309\u2013319. This is an important study of vaccine-strain viruses from two fatal cases of vaccine-associated viscerotropic disease. It includes animal inoculation studies.","journal-title":"Virology"},{"key":"22_CR40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4269\/ajtmh.1975.24.115","volume":"24","author":"M Theiler","year":"1975","unstructured":"Theiler M, Anderson CR: The relative resistance of dengueimmune monkeys to yellow fever virus. Am J Trop Meg Hyg 1975, 24:115\u2013119.","journal-title":"Am J Trop Meg Hyg"},{"key":"22_CR41","volume-title":"Health Information for International Travel 2003\u20132004","author":"Centers for Disease Control and Prevention","year":"2003","unstructured":"Centers for Disease Control and Prevention: Health Information for International Travel 2003\u20132004. Atlanta: US Department of Health and Human Services, Public Health Service; 2003. http:\/\/www.cdc.gov\/travel\/yb\/toc.html."},{"key":"22_CR42","doi-asserted-by":"crossref","first-page":"954","DOI":"10.4269\/ajtmh.2001.65.954","volume":"65","author":"I Potasman","year":"2001","unstructured":"Potasman I, Pick N, Stringer C, et al.: Inadequate protection against yellow fever of children visiting endemic areas. Am J Trop Med Hyg 2001, 65:954\u2013957.","journal-title":"Am J Trop Med Hyg"},{"key":"22_CR43","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1093\/infdis\/168.6.1520","volume":"168","author":"TF Tsai","year":"1993","unstructured":"Tsai TF, Paul R, Lynberg MC, Letson GW: Congenital yellow fever virus infection after immunization in pregnancy. J Infect Dis 1993, 168:1520\u20131523.","journal-title":"J Infect Dis"},{"key":"22_CR44","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0035-9203(93)90156-K","volume":"87","author":"A Nasidi","year":"1993","unstructured":"Nasidi A, Monath TP, Vanderberg J, et al.: Yellow fever vaccination and pregnancy: a four-year prospective study. Trans R Soc Trop Med Hyg 1993, 87:337\u2013339.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"22_CR45","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/00006454-199712000-00015","volume":"16","author":"TS Sibailly","year":"1997","unstructured":"Sibailly TS, Wistor SZ, Tsai TF, et al.: Poor antibody response to yellow fever vaccination in children infected with human immunodeficiency virus type 1. Pediatr Infect Dis J 1997, 16:1177\u20131179.","journal-title":"Pediatr Infect Dis J"},{"key":"22_CR46","first-page":"145","volume":"2","author":"M Goujon","year":"1995","unstructured":"Goujon M, Tohr M, Feuillie V, et al.: Good tolerance and efficacy of yellow fever vaccine among carriers of human immunodeficiency virus. J Travel Med 1995, 2:145.","journal-title":"J Travel Med"},{"key":"22_CR47","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1086\/314031","volume":"31","author":"MC Receveur","year":"2000","unstructured":"Receveur MC, Thiebaut R, Vedy S, et al.: Yellow fever vaccination of human immunodeficiency virus-infected patients: report of 2 cases. Clin Infect Dis 2000, 31:E7-E8.","journal-title":"Clin Infect Dis"},{"key":"22_CR48","first-page":"131","volume":"85","author":"K Kengsakul","year":"2002","unstructured":"Kengsakul K, Sathirapongsasuti K, Punyagupta S: Fatal myeloencephalititis following yellow fever vaccination in a case with HIV infection. J Med Assoc Thai 2002, 85:131\u2013134.","journal-title":"J Med Assoc Thai"},{"key":"22_CR49","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1046\/j.1365-3156.1999.00496.x","volume":"4","author":"M Neidrig","year":"1999","unstructured":"Neidrig M, Lademann M, Emmerich P, Lafrenz M: Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA. Trop Med Int Health 1999, 4:867\u2013871.","journal-title":"Trop Med Int Health"},{"key":"22_CR50","first-page":"895","volume":"59","author":"JD Poland","year":"1981","unstructured":"Poland JD, Calisher CH, Monath TB, et al.: Persistence of neutralizing antibody 30\u201335 years after immunization with 17D yellow fever vaccine. Bull World Health Organ 1981, 59:895\u2013900.","journal-title":"Bull World Health Organ"},{"key":"22_CR51","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/S0140-6736(01)07185-9","volume":"385","author":"N Nathan","year":"2001","unstructured":"Nathan N, Barry M, Van Herp M, Zeller H: Shortage of vaccines during a yellow fever outbreak in Guinea. Lancet 2001, 385:2129\u20132130.","journal-title":"Lancet"},{"key":"22_CR52","first-page":"349","volume":"78","author":"World Health Organization","year":"2003","unstructured":"World Health Organization: Yellow fever vaccine. Wkly Epidemiol Rec 2003, 78:349\u2013360.","journal-title":"Wkly Epidemiol Rec"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-004-0022-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11908-004-0022-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-004-0022-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:21:59Z","timestamp":1559434919000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11908-004-0022-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["22"],"URL":"https:\/\/doi.org\/10.1007\/s11908-004-0022-5","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}